Using a Trigger Tool to Assess Adverse Drug Events in a Children's Rehabilitation Hospital

Kelly J Burch1

  • 1Your Child's Pharmacist, St. Louis, Missouri, and Ranken Jordan - A Pediatric Speciality Hospital, St. Louis, Missouri.

Insights

Pediatric rehabilitation patients experienced more adverse drug events (ADEs) per patient than those in tertiary care. However, ADEs were less frequent per day, indicating a need for targeted monitoring in rehabilitation settings.

Area of Science:

  • Pediatric pharmacology
  • Patient safety
  • Healthcare quality improvement

Background:

  • Adverse drug events (ADEs) are a significant concern in hospitalized children.
  • Trigger tools are validated methods for identifying ADEs across diverse patient populations.
  • Previous studies focused on ADEs in tertiary care, necessitating research in pediatric rehabilitation.

Purpose of the Study:

  • To compare the frequency and severity of ADEs in pediatric rehabilitation patients versus those in tertiary care.
  • To assess the risk of ADEs in pediatric rehabilitation, considering polypharmacy and clinical stability.
  • To evaluate the effectiveness of a pediatric inpatient trigger tool in identifying unreported ADEs.

Main Methods:

  • A pediatric inpatient trigger tool was applied to three groups of children in a rehabilitation setting.
  • ADE frequencies and patient characteristics were compared with data from a multicenter tertiary care study.
  • ADE frequency trends were analyzed over three assessment periods (2005, 2006, 2008).

Main Results:

  • The trigger tool identified ADEs that were not voluntarily reported.
  • ADE frequencies per patient were higher in rehabilitation settings compared to tertiary care.
  • ADE frequencies per day were lower with longer lengths of stay.
  • A trend of increasing ADE frequency over time was observed, linked to patient acuity.

Conclusions:

  • Systematic chart review with trigger tools effectively uncovers unreported ADEs.
  • While less frequent per day, ADEs in pediatric rehabilitation are more common per patient and per medication.
  • Understanding ADE types and severity in rehabilitation guides focused monitoring and care improvements.
Abstract

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...